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Abstract
Inositol 1,4,5-trisphosphate receptors (InsP3R) and ryanodine receptors (RyR) are tetrameric
intracellular Ca2+ channels1. For each, the pore is formed by C-terminal transmembrane domains
and regulated by signals detected by the large cytosolic structures. InsP3R gating is initiated by
InsP3 binding to the InsP3-binding core (IBC, residues 224-604 of InsP3R1)2 and it requires the
suppressor domain (SD, residues 1-223)2-8. We present structures of the N-terminal region (NT)
of InsP3R1 with (3.6 Å) and without (3.0 Å) InsP3 bound. The arrangement of the three NT
domains, the SD, IBC-β and IBC-α, identifies two discrete interfaces (α and β) between the IBC
and SD. Similar interfaces occur between equivalent domains (A, B and C) in RyR19. The
orientations of the three domains docked into a tetrameric structure of InsP3R10 and of the ABC
domains in RyR9 are remarkably similar. The importance of the α-interface for activation of
InsP3R and RyR is confirmed by mutagenesis and, for RyR, by disease-causing mutations9,11,12.
InsP3 causes partial closure of the clam-like IBC, disrupting the β-interface and pulling the SD
towards the IBC. This reorients an exposed SD loop (HS-loop) that is essential for InsP3R
activation7. The loop is conserved in RyR and includes mutations associated with malignant
hyperthermia and central core disease9,11,12. The HS-loop interacts with an adjacent NT,
suggesting that activation re-arranges inter-subunit interactions. The A-domain of RyR
functionally replaced the SD in a full-length InsP3R, and an InsP3R in which its C-terminal
transmembrane region was replaced by that from RyR1 was gated by InsP3 and blocked by
ryanodine. Activation mechanisms are conserved between InsP3R and RyR. Allosteric modulation
of two similar domain interfaces within an N-terminal subunit re-orients the first domain (SD or
A-domain), allowing it, via interactions of the second domain of an adjacent subunit (IBC-β or B-
domain), to gate the pore.
Correspondence and requests for materials should be addressed to C.W.T (cwt1000@cam.ac.uk) or M.I.
(mikura@uhnres.utoronto.ca)..
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The essential role of the SD in linking InsP3 binding to InsP3R gating highlights the need to
define the structural consequences of InsP3 binding to the NT (residues 1-604 of InsP3R1)
(Supplementary Fig. 1). Because our attempts to crystallize the NT yielded poorly
diffracting crystals, we expressed a Cys-less form of the NT (NTCysless). Native and Cys-
less forms of the NT and IBC behaved indistinguishably (Supplementary Fig. 2 and
Supplementary Tables 1-2), but NTCysless provided crystals with much improved diffraction
(Supplementary Table 3). We determined crystal structures of NTCysless with (3.6 Å) and
without (3.0 Å) InsP3 bound, showing three subdomains: the SD, IBC-β (residues 224-436)
and IBC-α (residues 437-604) (Fig. 1a). The structures of these subdomains were nearly
identical to those of isolated native SD and IBC2,3 (Supplementary Fig. 3).
The SD, IBC-β and IBC-α form a triangular structure, with the SD behind the InsP3-binding
site (Fig. 1a). The SD interacts via two interfaces with the IBC, one with IBC-β (β-interface)
and another with IBC-α (α-interface). A 310-like turn between the last strand of the SD and
the first strand of IBC-β positions the IBC relative to the SD (Supplementary Fig. 4e).
Within this connecting turn, a salt bridge (K225/D228) stabilizes the backbone conformation
and so positions residues that form the β-interface. These interactions in the connecting turn
and β-interface are augmented by a network of hydrophobic interactions within IBC-β (Fig.
1b). The α-interface forms a long ‘Velcro’-like structure that also involves a network of
hydrophobic and electrostatic interactions (Fig. 1c). Intimate hydrophobic interactions
between V33, and to a lesser extent L32, from the SD; and V452, F445, A449 and L476
from IBC-α are supported by bidentate salt bridges between R54/K127 in the SD and D444
in IBC-α (Fig. 1c). The V33K mutation at the α-interface almost abolished inhibition of
InsP3 binding by the SD3,4 and reduced channel open probability4, confirming its
importance. Mutation of neighbouring residues that contribute less to the α-interface (L32K,
D34K, R36E, K127E) had lesser effects on InsP3 binding, while mutation of residues that do
not contribute to the interface (D35K, K52E) had no effect (Supplementary Table 4)3,4.
Hydrophobic and electrostatic interaction networks at the α- and β-interfaces contribute to a
buried surface between the SD and IBC (~2040 Å2) that forms a hub connecting InsP3
binding to channel activation.
The structure of the NT is remarkably similar to that of the N-terminal of RyR19. The three
NT domains of InsP3R1 (SD, IBC-β and IBC-α) can be individually superposed to
corresponding domains of RyR1 (A, B and C) (Supplementary Fig. 3), and the relative
orientation of the domains is nearly identical (Fig. 1d). Mutation of Y167A, located on an
exposed loop of the SD opposite the IBC interfaces (‘HS-loop’11, residues 165-180, boxed
in Fig. 1d), attenuates InsP3-evoked Ca2+ release8; and Ca2+, a co-regulator of InsP3R14,
causes the loop to become accessible.15 The disease-associated ‘hot spot loop’ of RyR111
sits at the same location within the ABC structure9 (Fig. 1d) and a mimetic peptide causes
RyR2 to become leaky16. Furthermore, the backbone and side chain conformation of this
loop region superposes well in the two receptors (Fig. 1e). The HS-loop provides a critical
link between InsP3 binding and gating.
The domain interfaces of InsP3R1-NT and RyR1-ABC are also similar. The bidentate salt
bridges between R54/K127 and D444 at the InsP3R1 α-interface are preserved in RyR1
ABC, albeit in a reversed-charge manner between D40/D61 and R402 (Supplementary Fig.
4a). In RyR1, mutation of these residues (R402C, D61N) is associated with malignant
hyperthermia and central core disease9, suggesting that disruption of the interaction perturbs
RyR gating, as it does for InsP3R. The structural similarities extend also to the β-interface of
InsP3R1 and corresponding A/B interface in RyR1 (Supplementary Fig. 4b-d).
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Our structures of NTCysless with and without InsP3 bound, together with that of the InsP3-
bound IBC2 (Supplementary Fig. 5) reveal the structural changes evoked by InsP3 (Fig. 2).
Side chains of nine residues become organized around InsP3 (Supplementary Fig. 5a), and
the domain orientation angle between IBC-β and IBC-α is reduced (by ~8°) after InsP3
binding (Fig. 2 and Supplementary Fig. 5a). This InsP3-evoked ‘clam closure’, which is
consistent with earlier predictions17 and small-angle X-ray scattering18, causes the distance
across the entrance to the InsP3-binding pocket to decrease (Supplementary Fig. 5b, c). A
similar agonist-evoked domain closure occurs in some glutamate receptor channels19. The
SD and IBC remain associated after closure of the IBC (Fig. 2). InsP3 binding hardly
changes the interactions across the extensive α-interface, but at the β-interface the SD
residues move away from IBC-β (Supplementary Fig. 5d-f). With the SD glued to IBC-α by
the α-interface, and the β-interface serving as a lubricant, InsP3 binding causes the SD to
twist (by ~9°) and move closer to the top of the IBC (Fig. 2). This causes an amplified
translational movement of the conserved HS-loop in the SD (Supplementary Fig. 5g). While
our work was under review, 3.8 Å structures of apo- and InsP3-bound NT derived from a
single crystal grown in excess InsP3 were published, showing similar InsP3-induced
allostery in the interfaces between domains13. This confirms our observations, but our
higher resolution structures reveal more detail of the α- and β-interfaces associated with this
conformational change (Supplementary Discussion).
Docking the ABC structure into cryo-EM maps of RyR1 showed that the N-terminal
domains form a central ring at the top of the mushroom-like RyR19. Rigid-body docking of
our apo-NTCysless structure into a cryo-EM 10 Å structure of a closed InsP3R110 reveals an
arrangement remarkably similar to that of RyR1 with a high docking contrast (Fig. 3 and
Supplementary Fig. 6). The three domains of the four NTs, which form the upper
cytoplasmic surface of the mushroom-like InsP3R, are arranged as four hillocks around a
central bowl. This arrangement allows InsP3 unrestricted access to the IBC from the side of
the cap (Fig. 3), and it is consistent with accessibility studies and binding sites for regulatory
proteins (Supplementary Fig. 6c and Supplementary Table 5). Within the tetrameric InsP3R,
the only contacts between NT subunits are via the critical HS-loop of the SD and a flexible
loop (β20-β21, Supplementary Fig. 7) in IBC-β (Fig. 3c, d). The latter is longer in RyR and
it lies ~10 Å further from the neighbouring hot spot loop9 (Fig. 3c, d). In InsP3R, the arm
domains (residues 67-109) of each SD are the only NT structures that extend beyond the cap
towards the pore (Fig. 3a), but these domains are neither essential for InsP3R activation8 nor
conserved in RyR9,11.
The structural similarities between the N-termini of RyR and InsP3R prompted us to
examine whether the domains are functionally interchangeable. In a chimeric N-terminal
fragment comprising the A-domain of RyR2 and IBC from InsP3R1 (RyR2A-IBC), the A-
domain mimicked the SD by inhibiting InsP3 binding (Fig. 4a, b). Mutations within the A-
domain loop that forms the A-B interface in RyR9 or the equivalent InsP3R loop in the SD
attenuated this inhibition of binding (Fig. 4c, Supplementary Table 6 and Supplementary
Fig. 8). InsP3 stimulated Ca2+ release via InsP3R1 or a chimeric InsP3R1 in which the SD
was replaced by the A-domain of RyR1 (RyR1A-InsP3R1 (Fig. 4a, d and Supplementary
Fig. 9). Both InsP3Rs were similarly expressed and they released similar fractions of the
Ca2+ stores and with similar sensitivity to InsP3 (Supplementary Table 7). Opening of native
InsP3R or RyR is restrained by interactions between cytosolic domains20,21. It is therefore
significant that expression of InsP3R1 or RyR1A-InsP3R1 affected neither the Ca2+ content
of the ER nor the Ca2+ leak from it (Supplementary Fig. 10), confirming that InsP3R and
RyR1A-InsP3R1 have no detectable spontaneous activity. This demonstrates that the SD of
InsP3R can be functionally substituted by the A-domain of RyR.
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An InsP3R1 in which residues downstream of TMD1 were replaced by the equivalent region
of RyR1 (InsP3R1-RyR1) also responded to InsP3 (Fig. 4a,e). Expression of InsP3R1-RyR1
increased Ca2+ leak from the ER, and this was reversed by ryanodine, which blocks the RyR
pore22. However, the increased leak was insufficient to affect the steady-state Ca2+ content
(Supplementary Fig. 10), suggesting that InsP3R1-RyR1 has minimal spontaneous activity.
Expression of InsP3R1-RyR1 matched that of other InsP3Rs, but cells expressing InsP3R1-
RyR1 were ~20-fold less sensitive to InsP3 (Supplementary Table 7). Because the TMDs
minimally affect InsP3 binding23, this diminished response probably reflects a decrease in
InsP3 efficacy. The increased Ca2+ leak and reduced efficacy of InsP3 suggest that within
InsP3R1-RyR, communication between the SD and channel are slightly less effective than in
native InsP3R. Nevertheless, it is remarkable that cytosolic domains of an InsP3R should so
effectively regulate the pore of a RyR when the two receptors share only modest sequence
identity and differ in the number of residues separating the NT from TMDs (Fig. 4a), and in
the lengths and sequences of their C-terminal tails and the loops linking TMDs
(Supplementary Fig. 11).
Ryanodine (10 μM) had no effect on InsP3R1 or RyR1A-InsP3R, but it abolished InsP3-
evoked Ca2+ release via InsP3R1-RyR1 (Fig. 4e, f). Because ryanodine binds selectively to
active RyR24, 3H-ryanodine binding is stimulated by agonists of RyR, like caffeine.
Whereas caffeine had no effect on specific 3H-ryanodine binding to InsP3R1-RyR1, InsP3
stimulated it (Fig. 4g). InsP3 therefore causes conformational changes to the channel of
InsP3R1-RyR1 that mimic those of native RyR in allowing binding of 3H-ryanodine.
Conservation of structure-function relationships between InsP3R and RyR (Fig. 1-4) allows
comparisons between them to suggest possible mechanisms of InsP3R activation. For both
receptors, gating requires that conformational changes in the large cytoplasmic structures
pass to the TMDs10,22, but the N-terminal domains of InsP3R and RyR are at least 60 Å
from these TMDs1,9,22 (Fig. 3a and Supplementary Fig. 6). Despite some evidence
implicating direct interactions between the SD and TMD4-5 loop in gating InsP3R
(Supplementary Discussion), we suggest, and in keeping with results from RyR20,26,27, that
additional cytosolic domains couple the NT to opening of the pore. The exposed HS-loop in
the SD (Fig. 1d and 3c,d) (hot spot-loop of RyR)9,11 is arranged similarly within the isolated
N-terminal structures of InsP3R and RyR (Fig. 1d) and it reorients after InsP3 binding (Fig.
2). When the NT is docked into the InsP3R structure10, the HS-loop forms (with an exposed
loop of IBC-β) the only interface between adjacent NT, however, the equivalent loop is
displaced in the RyR9 (Fig. 3c, d). InsP3 binding closes the clam-like IBC, disrupting the β-
interface and re-orienting the HS-loop (Fig. 2 and Supplementary Fig. 5). This, we suggest,
disrupts interaction of the HS-loop with a neighbouring NT to cause a coordinated re-
arrangement of the apical InsP3R structure (Fig. 3). The open state of RyR1 is associated
with outward movement of protein density in regions that match the locations of docked
ABC structures9,22 and with larger movements of peripheral ‘clamp domains’9,22 that are
absent from InsP3R10. Movement of these apical domains in RyR is accompanied by re-
arrangements within regions that taper towards the pore22 and which, in InsP3R, include the
most flexible parts of its structure10. We suggest that similar rearrangements of the apical
surface of InsP3R and RyR couple by shared mechanisms to additional cytosolic domains to
gate the pore of each channel.
METHODS SUMMARY
The N-terminal (NT, residues 1-604) of rat InsP3R1 in which all Cys were replaced by Ala
(NTCysless) was expressed in E. coli and purified. Crystals of NTCysless were grown by the
hanging-drop vapour diffusion method in 0.1 M Hepes pH 7.0, 0.8-1.0 M (NH4)2SO4, and
3% (v/v) trimethylamine N-oxide for apo-state crystals, or 0.1 M Na citrate (pH 6.0), 8% (w/
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v) PEG-6000, 70 mM Li2SO4, 3% dimethyl sulfoxide for InsP3-bound crystals. Diffraction
data were collected at 100 K on the 19-ID (apo-crystals) or 19-BM (InsP3-bound crystals)
beam lines at the Advanced Photon Source Synchrotron facility (Argonne, IL) and processed
with HKL200028. Structures of apo-NTCysless at 3.0 Å resolution and InsP3-bound NTCysless
at 3.6 Å resolution were determined by molecular replacement using structures of the SD
(PDB code: 1XZZ)3 and the IBC (1N4K)2 as search models with the program Phaser29.
Iterative refinement and model building were performed with Refmac5 and Coot,
respectively. Numbering of secondary structure motifs is in accord with Supplementary
Figure 7. Binding of 3H-InsP3 or 3H-ryanodine to full-length InsP3R1, chimeras of InsP3R1
and RyR, and to related N-terminal fragments was defined using equilibrium-competition
binding assays4. Functional properties of InsP3R1 and chimeras were characterized after
stable expression in DT40 cells lacking endogenous InsP3R4. A luminal Ca2+ indicator was
used to record InsP3-evoked Ca2+ release from the intracellular stores of permeabilized
DT40 cells4.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Appendix
METHODS
Materials
InsP3 was from Enzo Life Sciences (Exeter, UK). Adenophostin A was from A. G.
Scientific (San Diego, CA, USA). Ryanodine was from Ascent Scientific (Bristol, UK).
Cyclopiazonic acid was from Sigma (St. Louis, MO). Sources of other materials are
specified in earlier publications2-4,18 or in the descriptions that follow.
Cloning, expression and purification of N-terminal fragments of InsP3R1 and RyR2
The open reading frame (ORF) encoding the N-terminal fragment (NT, residues 1-604) of
rat InsP3R1 (GenBank: GQ233032.1) was amplified by PCR from the full-length clone
lacking the S1 splice site using forward 5′-
CGGGATCCATGTCTGACAAAATGTCTAGT-3′ and reverse 5′-
CGCGCTCGAGTCACTTTCGGTTGTTGTGGA-3′ primers. The PCR product was ligated
into a pGEX-6P-2 vector (GE Healthcare, Little Chalfont, Bucks, UK) as a BamHI/XhoI
fragment to give pGEX(NT), which includes an N-terminal GST tag followed by a
PreScission-cleavage site. To generate NTCysless, a QuikChange multisite directed
mutagenesis kit (Agilent, Stockport, UK) was used to mutate all Cys residues to Ala using
pGEX-6P-2-(NT) as the template and the primers listed in Supplementary Table 8. Residues
are numbered by reference to rat InsP3R1 containing the S1 splice site.
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Plasmids encoding GST-tagged IBC (residues 224-604) and IBCCysless were generated using
PCR to amplify the appropriate sequence from the ORF of full-length rat InsP3R1 or
NTCysless using the following primers: forward 5′-
CGGGATCCATGAAATGGAGTAACAAAG-3′ and reverse 5′-
CGCGCTCGAGTCACTTTCGGTTGTTGTGGA-3′. Each PCR product was ligated into a
pGEX-6P-2 vector as a BamHI/Xho I fragment to produce pGEX-6P-2-(IBC) and
pGEX-6P-2-(IBCCysless), respectively. For analysis of the effects of mutations within the SD
on InsP3 binding, the plasmids described previously were used to express His6-tagged NT
and IBC4 and the His6-tag was cleaved prior to experiments4. Mutations were introduced
using a QuikChange mutagenesis kit and the primers listed previously4 or in Supplementary
Table 9.
The sequence encoding the A-domain of RyR2 was amplified by PCR from rabbit RyR2
(GenBank: GI164831)30 in pcDNA3 using the following primers: forward 5′-
ACTAGTCTCGAGGTGCTCTTCCAGGGGCCCATGGCTGATGGGGGCGAA-3′ and
reverse 5′-GATATCCTTCACTTCCTGAGCTGATGGG-3′. The ORF for the IBC of
InsP3R1 was excised from pGEX-6P-2-(NT) as a BamHI/XhoI fragment and ligated into a
pET41a vector to produce pET41a-(IBC). To generate a plasmid encoding a chimeric NT in
which the A-domain of RyR2 (residues 1-210) was fused to the IBC of InsP3R1 (residues
225-604) (RyR2A-IBC), the PCR product from above was ligated into pET41a-(IBC) as a
SpeI/EcoRV fragment to produce pet41a-(RyR2A-IBC). Mutations within the ORF of the
A-domain of RyR2A-IBC were generated by site-directed mutagenesis using the
QuikChange Lightning mutagenesis kit (Stratagene) using the primers listed in
Supplementary Table 9. The complete coding sequences of all constructs were confirmed by
sequencing. The sequences of the proteins used are summarized in Supplementary Table 1
and Figure 4a.
For structural studies, NTCysless was expressed as a GST-fusion protein in BL21-
CodonPlus(DE3) E. coli strain. Transformed cells were first grown at 37°C until the OD600
reached ~1.0 and then induced with 0.5 mM IPTG at 15°C for ~18 h. Proteins were purified
using glutathione sepharose 4B resin (GE Healthcare), and the GST tag was cleaved from
the eluted proteins with PreScission protease (GE Healthcare) during overnight dialysis at
4°C in cutting buffer (20 mM Tris-HCl, pH 8.4, 300 mM NaCl, 5% glycerol, 2 mM DTT).
The cleaved proteins were further purified with cation-exchange chromatography (Fractogel
EMD SO3-resin, EM Industries Inc.) followed by size-exclusion chromatography (Superdex
200, GE Healthcare). Purified proteins were concentrated to 14 mg/ml in a buffer
comprising 20 mM Tris-HCl, pH 8.4, 360 mM NaCl, 2.5% glycerol, 0.2 mM TCEP, 1 mM
PMSF. Similar methods were used to express InsP3R fragments for binding studies, but with
the following modifications: bacteria were initially grown at 22°C, the GST-tag was cleaved
by incubation of bacterial lysates immobilized on glutathione sepharose 4B resin with
PreScission for 5 h in PreScission-cleavage buffer (GE Healthcare). The eluant was then
used for 3H-InsP3 binding analyses without further purification. Western blotting and silver-
stained gels were used to verify expression and purification of NT fragments.
Western blotting
Western blotting of DT40 cells solubilized in TEM containing Triton-X100 (1% v/v) was
performed as previously described31 using anti-peptide antisera corresponding to residues
240-253 within the IBC (AbNT, 1:1000) or 2733-2749 (AbCT, 1:500) of rat InsP3R1. The
secondary antibody was HRP-conjugated donkey anti-rabbit antibody (1: 5000, Santa Cruz
Biotechnology).
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3H-InsP3 Binding
Equilibrium-competition binding assays were performed at 4°C in Tris-EDTA medium
(TEM: 50 mM Tris, 1 mM EDTA, pH 8.3) containing 3H-InsP3 (0.75 nM, Perkin-Elmer
Life Sciences), purified protein (1-4 μg) and unlabelled InsP3 in a final volume of 500 μl.
After a 5-min incubation, during which equilibrium was attained, reactions were terminated
by addition of 500 μl of TEM containing 30% poly(ethylene glycol) 8000 and γ-globulin
(750 μg) followed by centrifugation (20,000 g, 5 min). For 3H-InsP3 binding to IBC, the
amount of 3H-InsP3 was reduced to 0.25 nM, and incubation volumes were doubled. Pellets
were solubilized in 200 μl of TEM containing 2% Triton-X 100 (v/v), mixed with
EcoScintA scintillation liquid (National Diagnostics) and radioactivity was determined by
liquid scintillation counting. Non-specific binding was determined in the presence of 10 μM
InsP3. Binding results were fitted to a Hill equation (GraphPad Prism, version 5) from which
pIC50 (-logIC50, where IC50 is the half-maximal inhibitory concentration) and thereby pKD
(-logKD) values were calculated32.
3H-ryanodine binding
Microsomal membranes were prepared from DT40 cells by lysis with a glass homogenizer
and sonication in cytosol-like medium (CLM) supplemented with protease inhibitors (Roche
complete protease inhibitor cocktail), followed by centrifugation (50,000 g, 30 min). CLM
had the following composition: 140 mM KCl, 20 mM NaCl, 1 mM EGTA, 20 mM Pipes, 2
mM MgCl2, 375 μM CaCl2 (free [Ca2+] ~ 220 nM), pH 7. Equilibrium-competition binding
was performed with microsomal membranes (100 μg protein/ml) at 4°C in 200 μl of CLM
supplemented with protease inhibitors and 3H-ryanodine (100 nM, Perkin-Elmer Life
Sciences). Reactions were terminated after 90 min, and radioactivity was determined as
described for 3H-InsP3 binding. Non-specific binding was defined by addition of 10 μM
unlabelled ryanodine.
3H-ryanodine binding to RyR typically requires many hours to reach equilibrium24 because
it binds only to the open state of the channel and spontaneous openings are rare. In our
analyses of 3H-ryanodine binding to InsP3R1-RyR1 (Fig. 4g) equilibrium was attained
within 90 min, perhaps because the modestly increased spontaneous activity of the chimeric
channel (Supplementary Fig. 10b) contributed to an increased rate of 3H-ryanodine binding
to the open state. In parallel comparisons, specific binding of 3H-ryanodine to InsP3R1-
RyR1 expressed in DT40 cells and stimulated with InsP3 (1 μM) was (d.p.m.; mean [range]
for 2 independent experiments): 4241 [4073-4409] after 90 min, 4941 [4825-5058] after 3 h,
and 4410 [4108-4712] after 14 h. It is, however, important to note that our conclusion that
InsP3 selectively stimulates 3H-ryanodine binding to InsP3R1-RyR1 is not dependent on
having measured binding under equilibrium conditions.
Crystallization and data collection
Crystals of apo-NTCysless were grown by the hanging-drop vapour diffusion method at 293
K by mixing 1 μl of protein with an equal volume of reservoir solution (0.1 M Hepes, pH
7.0, 0.8-1.0 M (NH4)2SO4). Using an additives screen, 3% (v/v) trimethylamine N-oxide
was identified as an important additive to obtain single rod-shaped crystals. After a series of
microseeding trials, rod-shaped single crystals were obtained within 5 days. For
crystallization of InsP3-bound NTCysless, five molar excess of InsP3 (~1 mM) was added
before crystallization. Crystals of InsP3-bound NTCysless were grown using the same method
except for the reservoir solution containing 0.1 M Na citrate (pH 6.0), 8% (w/v) PEG-6000,
70 mM Li2SO4 and 3% dimethyl sulfoxide.
For data collection, crystals were equilibrated in 25% glycerol cryo-protective solutions
containing reservoir buffer, and flash frozen in liquid nitrogen. Diffraction data were
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collected at 100K on 19-ID beam line for apo-state crystals or 19-BM beam line for InsP3-
bound crystals at the Advanced Photon Source Synchrotron facility (Argonne, IL), and were
processed with HKL2000. Crystals of apo-NTCysless belong to the space group P1 with cell
dimension a=63.1 Å, b=77.2 Å, c=101.5 Å, α=105.4°, β=100.0°, γ=101.0°. Crystals of
InsP3-bound NTCysless belong to the space group C2 with cell dimension a=189.2 Å, b=78.7
Å, c=134.1 Å, α=90.0°, β=124.5°, γ=90.0°. Crystals of both apo- and InsP3-bound
NTCysless contained two molecules in the asymmetric unit (Supplementary Table 3).
Structure determination and refinement
Structures of apo-NTCysless at 3.0 Å resolution and of InsP3-bound NTCysless at 3.6 Å
resolution were determined by molecular replacement using structures of the SD (PDB code:
1XZZ)3 and the IBC (PDB code: 1N4K)2 as search models with the program Phaser29.
Iterative refinement and model building were performed with Refmac533 and Coot34,
respectively (Supplementary Table 3). Structures of the two molecules in the asymmetric
unit of apo-NTCysless are virtually identical (rmsd value = 0.543 Å) except for a minor
variation in the loop between β20 and β21 which does not affect the interpretation of our
results. The low rmsd between chain A and chain B is maintained through the regions of the
molecule which make up interface-α and interface-β, thus increasing the validity of our
description of the ‘open-clam’ structure. The two molecules in the asymmetric unit of InsP3-
bound NTCysless are more converged than those of the apo-structure (rmsd value = 0.134 Å),
which also validates our description of the ‘closed-clam’ structure. The molecule of chain A
for each state was used to generate figures, but the chain B molecule of apo-NTCysless was
used for the side chain of D444 in Fig. 1c. All water molecules were modeled in Coot34.
Initially, water molecules were detected using the automatic “find waters” function in the
program. A 2F0-Fc map was used with a sigma cut-off value of 1.0, and minimum and
maximum distances to protein atoms of 2.4 and 3.2 Å, respectively. We subsequently picked
additional water molecules and deleted inappropriate water molecules by manually
surveying the density in Coot. After refinement, all water molecules exhibiting negative
electron density due to inconsistent modeling were deleted.
Circular dichroism (CD) analysis
CD spectra were collected on a Jasco J-720 spectrometer using a 1-mm path length cuvette
at 20 °C. The NT and NTCysless (0.2 mg/ml) were prepared in a buffer (20 mM Tris-HCl, pH
8.4, 360 mM NaCl, 2.5% glycerol, 0.2 mM TCEP, 1 mM PMSF). CD spectra were obtained
from 260 to 200 nm, with a 2-nm bandwidth, an 8-s response time, and scan speed of 50 nm/
min. Data are averages of three consecutive scans.
Cloning and functional expression of chimeric InsP3R
To generate the plasmid encoding a chimeric InsP3R1 in which residues 2274-2748 of
InsP3R1 (all residues downstream of those immediately before TMD1) were replaced by the
equivalent region from RyR1 (residues 4511-5037) (InsP3R1-RyR1), the appropriate region
of the ORF of rabbit RyR1 (GenBank: X15209)35 was amplified by PCR from the
expression vector pcDNA3.2 using the following primers: forward, 5′-
CGCGGGTTCGAAGTCCCCGAGGCCCCACCAGAACCCCCC-3′, and reverse 5′-
CGGGGCGTCCTCGAGTCATTAGCTCAGCTGGTCCTCGTACTGCTTGCGGAAGC-3′
. The PCR product was cloned in-frame as a BstBI/XhoI fragment into a pENTR1a vector
containing nucleotides 1-6822 of rat InsP3R1. This construct was transferred into the
Gateway-compatible expression vector, pcDNA3.2, to generate pcDNA3.2-(InsP3R1-
RyR1). A plasmid encoding InsP3R lacking the SD was generated from ORFs for the full-
length InsP3R1 lacking the S1 splice site (pENTR1A(InsP3R1)) and the IBC
(pENTR1A(IBC)). Both plasmids were digested with NheI and KpnI, and the fragment from
pENTR1A(IBC) was cloned into pENTR1A(InsP3R1). Site-directed mutagenesis was then
Seo et al. Page 8
Nature. Author manuscript; available in PMC 2012 September 01.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
used to silence 3 internal BamHI sites within this construct without affecting the coding
sequence to generate the plasmid pENTR1A(InsP3R1ΔSD). A plasmid encoding a chimera in
which the SD of InsP3R1 (residues 1-224) was replaced by the A-domain of RyR1 (residues
1-210) (RyR1A-InsP3R) was prepared by isolating the coding sequence for the A-domain of
RyR1 by PCR from the the rabbit RyR1 ORF using the following primers: forward, 5′-
GCTAGCATCATGGGTGACGGAGGA-3′ and reverse 5′-
GGATCCTTCACAGCAGGAGCAGATG-3′. The PCR product was cloned as a NheI/
BamHI fragment into pENTR1A(InsP3R1ΔSD). The complete coding sequences of all
plasmids were verified by sequencing. Domain boundaries of the chimeric proteins are
summarized in Supplementary Table 1.
DT40-KO cells were transfected by electroporation with linearized plasmids (10 μg DNA/
106 cells) using the Neon (Invitrogen, Paisley, UK) or Amaxa (Lonza, Slough, UK)
nucleofection systems. G418 (2 mg/ml) was used to select and amplify clones of G418-
resistant cells. Stable cell lines were selected and InsP3R expression was measured by
Western blotting. DT40 cells were cultured in RPMI 1640 medium with L-glutamine
(Invitrogen) supplemented with 10% foetal bovine serum, 1% heat-inactivated chicken
serum (both from Sigma) and 10 μM 2-mercaptoethanol at 37°C in humidified air
containing 5% CO2. Cells (~2 ×106 cells/ml) were passaged every 2-3 days. Similar
methods were used for transient transfections with RyR1 and InsP3R1CyslessNT, but with 50
μg DNA/3 × 106 cells.
Functional analyses of InsP3R in DT40 cells
Uptake of Ca2+ into the intracellular stores of saponin-permeabilized DT40 cells and its
release by InsP3 were measured using a low-affinity Ca2+ indicator (Mag-fluo-4) trapped
within the endoplasmic reticulum36. All experiments were performed at 20°C in CLM
supplemented with 1.5 mM MgATP to allow active Ca2+ uptake. After the intracellular
stores had loaded to steady-state with Ca2+ (~150 s), InsP3 was added with thapsigargin (1
μM) to prevent further Ca2+ uptake (Supplementary Fig. 9). The effects of InsP3 were
assessed after a further 10-40 s. InsP3-evoked Ca2+ release is expressed as a fraction of the
ATP-dependent Ca2+ uptake. Typical experiments are shown in Supplementary Figure 9.
Structural model of RyR2A-IBC
A structural homology model of RyR2A-IBC (Fig. 4c) was produced using UCSF
Chimera37 to first superpose the backbone structures of apo-NTCysless and the ABC of RyR1
(PDB, 2XOA), the only RyR subtype for which there is a complete N-terminal structure9.
This A-domain structure of RyR1 was then used to allow superposition of the A-domain
from RyR2 (PDB, 3IM5)12, effectively achieving superposition of NTCysless onto a ‘virtual’
chimera of RyR2A with RyR1BC. The predicted structure of the RyR2A-IBC was then
revealed by masking the SD of InsP3R1 and the BC domains of RyR1 (Fig. 4c).
Computational docking
Rigid-body docking of the apo-NTCysless structure into a ~10 Å cryo-EM density map of
InsP3R110 was implemented using the six-dimensional search procedure in the Situs
Program package38. The Laplacian filter was applied to the density maps to enhance the
fitting contrast. Docking of the crystal structure of RyR1-ABC (PDB code: 2XOA) into a
9.6-Å cryo-EM density map (EMDB code: EMDB-1275)10, as previously described9, was
repeated using the above procedure. The UCSF Chimera package37 was used to visualize the
docking results with the density maps (Fig. 3 and Supplementary Fig. 6).
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Figure 1. Structure of the N-terminal region of InsP3R1 without InsP3 bound
a, Structure of NTCysless at 3 Å resolution showing SD (blue), IBC-β (green) and IBC-α
(yellow). Dashed lines show invisible regions in electron density. Positions of the three
domains within a single InsP3R subunit are shown. b, c, Interfaces between SD/IBC-β (β-
interface) (b) and SD/IBC-α domains (α-interface, with the hydrophobic core boxed and the
2Fo-Fc electron density map of key residues (contoured at 1.0 σ) shown as mesh) (c). d,
Superposition of apo-NTCysless and RyR1-ABC (grey)9 structures by overlaying IBC-β and
RyR1 B-domain. ‘Hot spot’ (HS) loop in RyR1 and corresponding region in InsP3R1 are
highlighted (red). e, Close-up views of HS regions of InsP3R1 (blue) and RyR1 (grey, black
lettering) with conserved residues depicted as sticks. Structure-based DALILite alignment of
rat InsP3R and rabbit RyR show conserved residues in yellow, RyR1 disease-associated
mutations in red, and hydrophobic residues implicated in activation of InsP3R in blue8.
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Figure 2. InsP3-evoked conformational changes
Superposition of apo-NTCysless (SD, blue; IBC-α, yellow; IBC-β, green) and InsP3-bound
NTCysless (3.6 Å resolution, magenta) by overlaying IBC-β domain. InsP3 binding causes
the SD to rotate towards the IBC accompanied by a swing approximately perpendicular to
the IBC ‘clam closure’. This twist (curved arrow) is measured as the angular difference
between the SD arm helices in the apo- and bound states (~9°). Movement of the HS-loop
(boxed) shows the distance between α-carbons of Y167 (~3.7 Å). A view rotated 90° about
the x-axis is shown at right with only IBCs represented. The interdomain (IBC-β and IBC-
α) angular difference between the free and bound states is ~8° (black arrow). Further details
of InsP3 binding and its effects on the IBC and α- and β-interfaces in Supplementary Figure
5.
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Figure 3. Docking of the apo-NTCysless structure into the cryo-EM map of InsP3R1
a, b, Side (a) and top (b) views of apo-NTCysless structure docked into the cryo-EM map
(grey mesh) of InsP3R1 in a closed state10. Contour level corresponds to mass of InsP3R1
tetramer of 1.3 MDa (protein density 0.8 Da/Å3). Four molecules of the NT (SD, blue; IBC-
β, green; IBC-α, yellow) are located at top of the cytoplasmic portion of the InsP3R1
tetramer. c, d, Dockings of the apo-NTCysless (coloured as in a) and ABC9 (grey) structures
into cryo-EM structures of InsP3R110 and RyR19, respectively, are overlaid and presented to
show only N-terminal structures. HS-loops of InsP3R (magenta) and RyR (orange) are
highlighted. Enlargement of boxed area (d). Locations of other binding sites within NT of
InsP3R1 are shown in Supplementary Figure 6.
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Figure 4. Functional chimeras of InsP3R and RyR
a, Proteins used. b, Specific binding of 3H-InsP3 in presence of adenophostin A. c,
Inhibition of 3H-InsP3 binding to IBC by SD or A-domain, and effects of mutations within
equivalent loops. Affinities shown relative to IBC (ΔpKD). Structures show key residues
within SD or A-domain at α-interface. d, Ca2+ release from DT40 cells expressing InsP3R1,
RyR1A-InsP3R1 or lacking InsP3R (KO). e, f, Effect of ryanodine (10 μM) on Ca2+ release
from DT40 cells expressing InsP3R1-RyR1 (e) or InsP3R1 (f). Ryanodine (≤10 μM) did not
stimulate Ca2+ release via InsP3R1-RyR1 suggesting that TMDs may not alone mediate
stimulation of RyR25. Results (d-f) are percentages of ATP-dependent Ca2+ uptake. g,
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Specific 3H-ryanodine binding (dpm, disintegrations/min) to membranes of DT40 cells
expressing InsP3R1 or InsP3R1-RyR1 with caffeine (10 mM) or InsP3 (1 μM). Non-specific
binding was 2245 ± 211 dpm. Results (b-g) are means ± s.e.m., n ≥ 3.
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